Baxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations
Baxter Healthcare is voluntarily recalling Clindamycin Phosphate Injection due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed in the US, Puerto Rico, and Chile.
- Product
- CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
- Category
- Drug
- Distribution
- Distributed nationwide